Cheyenne Wells, CONCT06995898Now EnrollingIRB Ready

Bladder Carcinoma Clinical Trial in Cheyenne Wells, CO

Access cutting-edge bladder carcinoma treatment through this clinical trial at a research site in Cheyenne Wells. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Cheyenne Wells location

Preparing your pre-screening questions…

Expert Care in Cheyenne Wells

Access bladder carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bladder carcinoma treatment provided free

Apply for This Cheyenne Wells Location

Check if you qualify for this bladder carcinoma clinical trial in Cheyenne Wells, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cheyenne Wells

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cheyenne Wells site if eligible
  4. 4Begin participation

About This Bladder Carcinoma Study in Cheyenne Wells

The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand how MCDs may work as cancer screening tools. The goal of cancer screening is to reduce the burden of cancer by identifying cancers before they show symptoms or signs, when treatment is likely to be most effective. In this study, adults aged 45-75 without cancer will be randomly assigned to one of 3 groups: 2 separate MCD test groups or a control group. These two MCD tests will not be compared to each other but will be compared to cancers detected in the control group. This study will provide early information on how well MCD tests perform as cancer screening tools. It will also help researchers understand how patients and their doctors make decisions about their care when the MCD test result comes back as normal (negative) or abnormal (positive).

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

Ages 45-75 years old
Agree to provide blood samples for possible MCD testing at enrollment and at 1 year following enrollment
Agree to allow collection of information from their medical records for study-related purposes
Understand and be able to complete informed consent and participant questionnaires in English, Spanish, or Arabic
Note: Eligibility for Spanish and Arabic languages are at the Hub's discretion

Exclusion Criteria

Solid malignant tumor or blood cancer diagnosis, with or without treatment, within the last 5 years
Note: Persons with a history of in situ cancers (e.g., ductal carcinoma in situ of the breast, cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ) or nonmelanoma skin cancer are eligible
Ongoing cancer diagnostic work-up
Ongoing participation in another study of an investigational cancer screening test or technology
Currently breastfeeding or pregnant, or planning to become pregnant in the next year

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cheyenne Wells?

Yes, this clinical trial (NCT06995898) has an active research site in Cheyenne Wells, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bladder Carcinoma Treatment Options in Cheyenne Wells, CO

If you're searching for bladder carcinoma treatment options in Cheyenne Wells, CO, this clinical trial (NCT06995898) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cheyenne Wells research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bladder carcinoma clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Cheyenne Wells, CO

See all bladder cancer clinical trials recruiting in Cheyenne Wells — not just this study.

Browse Bladder Cancer Trials in Cheyenne Wells

Ready to Join in Cheyenne Wells?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cheyenne Wells, CO